CCL21 and neoplasm: This work demonstrates that tumor hypoxia, by modulating the expression of molecules such as PDPN, leads to easier liberation of tumor cells and, lowering the NK cells recruitment upon CCL21 presentation, it impairs the anti-tumor immune defence.